Ozempic-like weight loss drug Mounjaro launched in India – all you know to know – The Times of India
Global pharmaceutical company Eli Lilly has launched Mounjaro (tirzepatide) in India. The drug, a single-molecule drug designed to bind to and activate both GIP and GLP-1 receptors, helps in regulating regulate blood sugar and metabolism. Approved by the Central Drugs Standard Control Organisation (CDSCO), the once-weekly injectable drug offers a novel approach to metabolic health…